Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10522895rdf:typepubmed:Citationlld:pubmed
pubmed-article:10522895lifeskim:mentionsumls-concept:C0020094lld:lifeskim
pubmed-article:10522895lifeskim:mentionsumls-concept:C0020095lld:lifeskim
pubmed-article:10522895lifeskim:mentionsumls-concept:C0147139lld:lifeskim
pubmed-article:10522895lifeskim:mentionsumls-concept:C0007806lld:lifeskim
pubmed-article:10522895lifeskim:mentionsumls-concept:C0076560lld:lifeskim
pubmed-article:10522895lifeskim:mentionsumls-concept:C0205527lld:lifeskim
pubmed-article:10522895lifeskim:mentionsumls-concept:C0376705lld:lifeskim
pubmed-article:10522895lifeskim:mentionsumls-concept:C1336626lld:lifeskim
pubmed-article:10522895lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:10522895lifeskim:mentionsumls-concept:C1442734lld:lifeskim
pubmed-article:10522895lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:10522895lifeskim:mentionsumls-concept:C0279477lld:lifeskim
pubmed-article:10522895lifeskim:mentionsumls-concept:C1707520lld:lifeskim
pubmed-article:10522895lifeskim:mentionsumls-concept:C1704619lld:lifeskim
pubmed-article:10522895lifeskim:mentionsumls-concept:C1533179lld:lifeskim
pubmed-article:10522895pubmed:issue6lld:pubmed
pubmed-article:10522895pubmed:dateCreated1999-12-17lld:pubmed
pubmed-article:10522895pubmed:abstractTextThe authors measured human T-cell lymphotrophic virus type I (HTLV-I) proviral load and intrathecal synthesis of antibodies to HTLV-I in CSF of 13 Brazilian patients with tropical spastic paraparesis/ HTLV-I-associated myelopathy (HAM). The authors also measured HTLV-I proviral load in peripheral blood mononuclear cells of five of these patients and found that it was 10- to 100-fold higher than that in CSF cells. The combination of HTLV-I proviral load and intrathecal synthesis of antibodies to HTLV-I appears to be a useful marker of disease progression. Patients with high viral load and no intrathecal synthesis of antibodies to HTLV-I had more rapidly progressing, serious clinical disease.lld:pubmed
pubmed-article:10522895pubmed:languageenglld:pubmed
pubmed-article:10522895pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10522895pubmed:citationSubsetAIMlld:pubmed
pubmed-article:10522895pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10522895pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10522895pubmed:statusMEDLINElld:pubmed
pubmed-article:10522895pubmed:monthOctlld:pubmed
pubmed-article:10522895pubmed:issn0028-3878lld:pubmed
pubmed-article:10522895pubmed:authorpubmed-author:OliveiraCClld:pubmed
pubmed-article:10522895pubmed:authorpubmed-author:RiosMMlld:pubmed
pubmed-article:10522895pubmed:authorpubmed-author:BiancoCClld:pubmed
pubmed-article:10522895pubmed:authorpubmed-author:NovisS ASAlld:pubmed
pubmed-article:10522895pubmed:authorpubmed-author:ZhuS WSWlld:pubmed
pubmed-article:10522895pubmed:authorpubmed-author:Puccioni-Sohl...lld:pubmed
pubmed-article:10522895pubmed:authorpubmed-author:Pombo-de-Oliv...lld:pubmed
pubmed-article:10522895pubmed:issnTypePrintlld:pubmed
pubmed-article:10522895pubmed:day12lld:pubmed
pubmed-article:10522895pubmed:volume53lld:pubmed
pubmed-article:10522895pubmed:ownerNLMlld:pubmed
pubmed-article:10522895pubmed:authorsCompleteYlld:pubmed
pubmed-article:10522895pubmed:pagination1335-9lld:pubmed
pubmed-article:10522895pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:10522895pubmed:meshHeadingpubmed-meshheading:10522895...lld:pubmed
pubmed-article:10522895pubmed:meshHeadingpubmed-meshheading:10522895...lld:pubmed
pubmed-article:10522895pubmed:meshHeadingpubmed-meshheading:10522895...lld:pubmed
pubmed-article:10522895pubmed:meshHeadingpubmed-meshheading:10522895...lld:pubmed
pubmed-article:10522895pubmed:meshHeadingpubmed-meshheading:10522895...lld:pubmed
pubmed-article:10522895pubmed:meshHeadingpubmed-meshheading:10522895...lld:pubmed
pubmed-article:10522895pubmed:meshHeadingpubmed-meshheading:10522895...lld:pubmed
pubmed-article:10522895pubmed:meshHeadingpubmed-meshheading:10522895...lld:pubmed
pubmed-article:10522895pubmed:meshHeadingpubmed-meshheading:10522895...lld:pubmed
pubmed-article:10522895pubmed:meshHeadingpubmed-meshheading:10522895...lld:pubmed
pubmed-article:10522895pubmed:meshHeadingpubmed-meshheading:10522895...lld:pubmed
pubmed-article:10522895pubmed:meshHeadingpubmed-meshheading:10522895...lld:pubmed
pubmed-article:10522895pubmed:meshHeadingpubmed-meshheading:10522895...lld:pubmed
pubmed-article:10522895pubmed:year1999lld:pubmed
pubmed-article:10522895pubmed:articleTitleAn inverse correlation of HTLV-I viral load in CSF and intrathecal synthesis of HTLV-I antibodies in TSP/HAM.lld:pubmed
pubmed-article:10522895pubmed:affiliationDivision of Neurology, Universidade Federal do Rio de Janeiro (HUCFF/UFRJ), Brazil.lld:pubmed
pubmed-article:10522895pubmed:publicationTypeJournal Articlelld:pubmed